Roche 454 Life Sciences and IDT Enter Worldwide Exclusive Agreement for Primer Design and Supply
News Sep 25, 2008
454 Life Sciences, a Roche company, and Integrated DNA Technologies, Inc., Coralville, USA announced that they have entered into an exclusive co-promotional agreement wherein IDT will design, synthesize, and purify the fusion primers required for certain 454 Sequencing applications.
These applications include ultra-deep amplicon sequencing for detection of low-frequency mutations in disease associated genes, and the comprehensive identification and quantification of common and rare variants within a population.
The partnership offers Genome Sequencer FLX System users a solution for primer creation, streamlining workflow and relieving bioinformatics burdens.
IDT's online fusion primer design tool uses a gen-specific data base number or a supplied reference sequence to build appropriate 454 FusionPrimers for targeted DNA regions, including individual exons or all exons from one or more genes.
DNA secondary structure, such as hairpin formation, can affect primer performance. The software takes into account performance metrics of the entire fusion primer rather than simply adding 454 Life Sciences’ universal adaptor sequence to an otherwise standard PCR primer.
In additional to 454 FusionPrimer design, IDT has expertise in high-fidelity synthesis and HPLC purification that can aid the researcher in obtaining the best quality data from their 454 sequencing System.
As the only next generation technology with the ability to sequence more than 400 bases per read, the Genome Sequencer FLX System enables comprehensive analysis, including haplotyping, of complete exons and other genomic regions.
A number of powerful applications are made possible by the system’s long reads and simplified by this new primer design tool. These research applications include ultra deep sequencing for detection of low-frequency somatic mutations in cancer samples, discovery of rare variants in HIV infected individuals, analysis of exon sequences of disease-associated regions, identified by whole genome association studies and sequencing of 16S ribosomal RNA regions to characterize the microbial abundance and diversity in metagenomic samples.
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018